1) polycrystalline wire-shaped materials
多晶丝材
2) polycrystalline materials
多晶材料
1.
Based on the principle of contrasting referring to Ag_ 2 Se-Ga_ 2 Se_ 3 pseudobinary phase diagram, AgGa_ 1-x In_ x Se_ 2 polycrystalline materials with a portion of In content were synthesized by mechanical and temperature oscillation method.
根据Ag2Se-Ga2Se3赝二元相图,对AgGa1-xInxSe2按同成分点配料,通过机械和温度振荡的方法合成出AgGa1-xInxSe2多晶材料。
2.
The main research methods,test results,influencing factors and the micro-mechanism of two types of scale effects,namely,"smaller is stronger" and "the smaller the more weak",occurred in micro-components of polycrystalline materials are particularly summarized.
结论是:微构件内、外尺寸的耦合关联影响控制了尺度效应和与其相对应的材料内在特征长度,今后如能进一步探明微构件外形结构尺寸、晶粒尺寸和材料内在特征长度与其性能异变之间的制约关系,基于晶体学和高阶理论建立较全面、系统的力学分析模型,将有可能揭示微构件多晶材料内在特征长度的微结构控制的机理,进而实现通过调控材料的微结构控制微构件的宏观力学性能。
3.
A new approach for investigation on the in-plane displacement on a grain scale for polycrystalline materials is proposed in this paper based on coupling digital image correlation method and a new type of microscope-digital microscope.
结合数字散斑相关方法和一种新型的显微镜数码显微镜,提出了一种测量多晶材料晶粒尺度面内变形的新方法,并通过零变形校准实验、重聚焦实验和平移实验等一系列验证实验分析了该方法的精度和实用性。
3) polycrystalline material
多晶材料
1.
One of the main trends towards the exploitation of sensing materials is to develop the single crystal materials into polycrystalline materials and amorphous materials.
对敏感功能材料研究开发所呈现的主要趋势之一就是从单晶材料向多晶材料和非晶材料方向过渡发展。
2.
Through the detailed analysis of the machining mechanism of micro-milling polycrystalline materials,a micro-milling model is developed,where the effects of minimum chip thickness and metal phase on the mechanism are focused on.
对微铣削多晶材料的加工机理进行了详细分析,建立了相应的加工过程模型。
3.
In order to research in the novel laser crystal of molybdate,the compound-anion polycrystalline material Yb3+:NaBi(WO4)(MoO4) was synthesized by solid state reaction.
为了研究新型的钼酸盐激光晶体材料,采用熔盐法固相反应合成了混酸盐多晶材料Yb3+:NaBi(WO4)(MoO4)。
5) Polycrystalline bulk
多晶块材
1.
At first,the La_(2/3)Sr_(1/3)MnO_3 polycrystalline bulk is synthesized through the chemical coprecipitation route innovatively and microstructure,electrical, magnetic and magnetoresistance for cor.
本论文较为系统地研究了庞磁电阻(colossal magnetoresistance,CMR)材料La_(2/3)Sr_(1/3)MnO_3多晶块材及(La_(2/3)Sr_(1/3)MnO_3)_(1-x)/(LaNiO_3)_x复合体系的制备、晶体结构、电磁性能、CMR效应等重要内容。
6) composite polycrystalline filament
复合多晶丝
补充资料:苄丝肼-左旋多巴,美多巴,复方苄丝肼胶囊
药物名称:美多巴
英文名:Medopa
别名:苄丝肼-左旋多巴,美多巴,复方苄丝肼胶囊
外文名:Benserazide-Levodopa, Madopar
适应症: 帕金森氏病、症状性帕金森氏综合症、(脑炎后、动脉硬化性或中毒性)。 参见“苄丝肼”.
用法用量:美多巴"250"片剂用法:
----------------------------------------------------------------------------------
早晨7:00 中午11:00 下午3:00 晚上7:00
----------------------------------------------------------------------------------
第一周 1/2 1/2 --- 1/2
----------------------------------------------------------------------------------
第二周 1/2 1/2 1/2 1/2
-----------------------------------------------------------------------------------
第三周 1 1/2 1/2 1/2
-----------------------------------------------------------------------------------
第四周 1 1 1/2 1/2
-----------------------------------------------------------------------------------
第六和七周 1 1 1 1/2
------------------------------------------------------------------------------------
第八和第九周 1 1 1 1
------------------------------------------------------------------------------------
规格:片剂:苄丝肼-左旋多巴25mg-100mg/片, 50mg-200mg/片.
类别:抗震颤麻痹药
英文名:Medopa
别名:苄丝肼-左旋多巴,美多巴,复方苄丝肼胶囊
外文名:Benserazide-Levodopa, Madopar
适应症: 帕金森氏病、症状性帕金森氏综合症、(脑炎后、动脉硬化性或中毒性)。 参见“苄丝肼”.
用法用量:美多巴"250"片剂用法:
----------------------------------------------------------------------------------
早晨7:00 中午11:00 下午3:00 晚上7:00
----------------------------------------------------------------------------------
第一周 1/2 1/2 --- 1/2
----------------------------------------------------------------------------------
第二周 1/2 1/2 1/2 1/2
-----------------------------------------------------------------------------------
第三周 1 1/2 1/2 1/2
-----------------------------------------------------------------------------------
第四周 1 1 1/2 1/2
-----------------------------------------------------------------------------------
第六和七周 1 1 1 1/2
------------------------------------------------------------------------------------
第八和第九周 1 1 1 1
------------------------------------------------------------------------------------
规格:片剂:苄丝肼-左旋多巴25mg-100mg/片, 50mg-200mg/片.
类别:抗震颤麻痹药
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条